Bone marrow cell therapy in cardiovascular disease drives us slowly to a better identification of the active cell component


Endothelial progenitor cell therapy and stem cell therapy have been proposed in regeneration of acute myocardial infarction (AMI). In the previous issue of Stem Cell Research & Therapy, Lamirault and colleagues described a strong analysis of progenitors in blood and bone marrow of patients collected after AMI, and correlated these levels to bone marrow… (More)
DOI: 10.1186/scrt405


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics